United States
Germany
Japan
United Kingdom
China
Recombinant Anti-CD52 (Clone YTH 34.5-G2b (Campath-1G))
| Applications | CT, ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
Antibodies
Recombinant Anti-CD52 (Clone Campath-1H)
| Applications | CT, ELISA, FC, IHC, WB |
| Reactivities | Human, Monkey |
CNY 6,881.00
6周
Recombinant Anti-IL-2R alpha (CD25) (Clone Basiliximab)
| Applications | Bl, FC, IF, IHC, WB |
| Reactivities | Human, Monkey |
Recombinant Anti-PD-L1 (Clone 332M7)
| Applications | Bl, FC |
| Reactivities | Human, Mouse, Monkey |
Recombinant Anti-CD18 (Clone 1B4)
| Applications | ELISA, FC, IF, IP, R |
| Reactivities | Human, Monkey |
Recombinant Anti-CD40 (Clone 5D12)
| Applications | Bl, ELISA, FC, IHC, IP |
| Reactivities | Human, Cynomolgus, Monkey |
Recombinant Anti-CD40 (Clone 5D12)
| Applications | Bl, ELISA, FC, IHC, IP |
| Reactivities | Human, Cynomolgus, Monkey |
Recombinant Anti-Fc gamma receptor III (Clone 3G8)
| Applications | Bl, FC, IHC, IP |
| Reactivities | Human, Chimpanzee, Baboon, Cynomolgus, Monkey, Macaque, Marmoset |
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
| Applications | Bl, FC, IP |
| Reactivities | Human, Monkey |
CNY 6,881.00
9周
Recombinant Anti-IL-2R (Clone Daclizumab)
| Applications | Bl, FC |
| Reactivities | Human, Monkey |
Recombinant Anti-PD-L1 (Clone 332M7)
| Applications | Bl, FC |
| Reactivities | Human, Mouse, Monkey |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
| Applications | FC |
| Reactivities | Human, Monkey |
Recombinant Anti-CD20 (Clone 10F381 (rituximab))
| Applications | FC |
| Reactivities | Human, Monkey |
